Pemetrexed monotherapy as salvage treatment in metastatic colorectal cancer patients who failed standard chemotherapy: A phase II single-arm prospective trial.

被引：0

作者：

Lim, Sung Won ^{[1
]}

Cho, Jangho ^{[1
]}

Lee, Jeeyun ^{[1
]}

Park, Se Hoon ^{[1
]}

Park, Joon Oh ^{[1
]}

Park, Young Suk ^{[1
]}

Lim, Ho Yeong ^{[1
]}

Kang, Won Ki ^{[1
]}

Kim, Seung Tae ^{[1
]}

机构：

[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期

关键词：

D O I：

10.1200/JCO.2018.36.4_suppl.840

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

840

引用

页数：1

共 50 条

[41] The efficacy and safety of anlotinib in neoadjuvant treatment in locally advanced thyroid cancer: A single-arm phase II clinical trial.
Huang, Naisi
Sun, Guohua
Wang, Yulong
Chen, Jiaying
Guan, Qing
Lu, Zhongwu
Xiang, Jun
Wei, Wenjun
Ma, Ben
Ji, Qinghai
Wang, Yu
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[42] A single-arm, phase II study of intrahepatic chemotherapy in patients with unresectable colorectal liver metastases
Besel, Kate Elenna
Ko, Yoo-Joung
Karanicolas, Paul Jack
Kim, Christina Yiyoung
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[43] Neoadjuvant pamiparib in patients with newly diagnosed advanced ovarian cancer: A single-arm, prospective phase II trial
Liu, Jing
Hu, Dan
Li, Li
Zang, Lele
Zhu, Fei
Zhu, Mingxuan
Zhang, Huiqi
Chang, Lele
Xu, Qin
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[44] Antitumor activity of bintrafusp alfa in previously treated patients with recurrent or metastatic nasopharyngeal cancer (NPC): A single arm, prospective phase II trial.
Chiang, Chi Leung
Lam, Tai Chung
Li, Chung Bong James
Li, Wing Sum
Chan, Sik-Kwan
Lee, Yim Ping Yolanda
Cheung, Ka Wai Alice
Chow, James Chung Hang
Chan, Po Chung Sunny
Man, Wai
Lee, Sarah
Lai, Wing Yu Jessica
El Helali, Aya
Ng, Wai-Tong
Kong, Feng-Ming Spring
Kwong, Dora L. W.
Lee, Wing Mui Anne
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18029 - E18029
[45] Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial
Kim, J. H.
Kim, S. H.
Jeon, M. K.
Kim, J. E.
Kim, K. H.
Yun, K. -H.
Jeung, H. -C.
Rha, S. Y.
Ahn, J. -H.
Kim, H. S.
ESMO OPEN, 2021, 6 (05)
[46] Sunitinib therapy in patients with metastatic colorectal cancer after failure of standard chemotherapy: Results of a phase II trial
Lenz, H.
Marshall, J.
Rosen, L.
Belt, R.
Hurwitz, H.
Eckhardt, S.
Bergsland, E.
Haller, D.
Chao, R.
Saltz, L.
ANNALS OF ONCOLOGY, 2006, 17 : 27 - 27
[47] Olaparib as salvage treatment for advanced germ cell tumors after chemotherapy failure: Results of the open-label, single-arm, IGG-02 phase II trial.
De Giorgi, Ugo
Schepisi, Giuseppe
Gurioli, Giorgia
Pisano, Carmela
Basso, Umberto
Lolli, Cristian
Petracci, Elisabetta
Casadei, Chiara
Cecere, Sabrina Chiara
Attademo, Laura
Clemente, Alberto
Zampiga, Valentina
Galla, Valentina
Cangini, Ilaria
Di Napoli, Marilena
Valmorri, Linda
Pignata, Sandro
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[48] An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
Van Cutsem, E.
Siena, S.
Humblet, Y.
Canon, J. -L.
Maurel, J.
Bajetta, E.
Neyns, B.
Kotasek, D.
Santoro, A.
Scheithauer, W.
Spadafora, S.
Amado, R. G.
Hogan, N.
Peeters, M.
ANNALS OF ONCOLOGY, 2008, 19 (01) : 92 - 98
[49] Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI study): A prospective, single-arm, phase II trial
Chen, Jing
Li, Kezhen
Hu, Yingjie
Han, Yingyan
Shen, Yuanming
Wang, Yanzhou
Song, Kun
Xia, Bairong
Chen, Xiaojun
Zou, Dongling
Wang, Yingmei
Sun, Chaoyang
Chen, Gang
Ma, Ding
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[50] Neoadjuvant tislelizumab plus chemotherapy among patients with advanced ovarian cancer: A prospective, single-arm, phase II study
Zhou, Jinhua
Liu, Wei
Huang, Yazhen
Ding, Hongmei
Chen, Youguo
GYNECOLOGIC ONCOLOGY, 2024, 190 : S298 - S299

← 1 2 3 4 5 →